{"id":"CHEMBL1007","canonicalSmiles":"CC(C)C[C@H](NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O","inchiKey":"XLXSAKCOAKORKW-AQJXLSMYSA-N","drugType":"Protein","blackBoxWarning":false,"name":"GONADORELIN","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fertiral lh-rh","Relefact lh-rh"],"synonyms":["Gonadorelin","Gonadorelin decapeptide","Gonadotropin-releasing hormone","Human gonadoliberin-i"],"crossReferences":{"chEBI":["5520"]},"childChemblIds":["CHEMBL1200516","CHEMBL1200511"],"linkedTargets":{"rows":["ENSG00000109163"],"count":1},"linkedDiseases":{"rows":["MONDO_0002146","EFO_0002610","EFO_0000545","EFO_1001757","EFO_0000731","EFO_0000673","MONDO_0007254","EFO_0003882","MONDO_0008315","Orphanet_478","MONDO_0018555","EFO_0001663"],"count":12},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and has 12 investigational indications."}
{"id":"CHEMBL1082738","canonicalSmiles":"c1ccc2c(NCCCCCCCCNc3c4c(nc5ccccc35)CCCC4)ccnc2c1","inchiKey":"UNVOAAWEEGAXTN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1082738","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04616"]},"childChemblIds":["CHEMBL542236"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1095607","canonicalSmiles":"Cn1c(=O)c2c(ncn2CCCNCC(O)c2cc(O)cc(O)c2)n(C)c1=O","inchiKey":"WVLAAKXASPCBGT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REPROTEROL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["D-1959","Reproterol"],"crossReferences":{"drugbank":["DB12846"]},"childChemblIds":["CHEMBL2104771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for airway obstruction and has 1 investigational indication."}
{"id":"CHEMBL1115","canonicalSmiles":"CN(C)C(=O)Oc1ccc[n+](C)c1","inchiKey":"RVOLLAQWKVFTGE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PYRIDOSTIGMINE","yearOfFirstApproval":1955,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Mestinon","Pyridostigmine","Pyridostigmine cation","Pyridostigmine ion","Regonol"],"crossReferences":{"DailyMed":["pyridostigmine%20bromide"],"PubChem":["11111694","90340824"],"Wikipedia":["Pyridostigmine"],"drugbank":["DB00545"],"chEBI":["8665"]},"childChemblIds":["CHEMBL812","CHEMBL4303667"],"linkedTargets":{"rows":["ENSG00000087085"],"count":1},"linkedDiseases":{"rows":["EFO_0005687","Orphanet_365","Orphanet_83419","MONDO_0100096","Orphanet_93961","MONDO_0005180","EFO_0000764","EFO_0003144","EFO_0005252","EFO_0004991","EFO_0000400","EFO_0005251"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1955 and is indicated for myasthenia gravis and has 11 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL111861","canonicalSmiles":"C[C@]12CC(=O)[C@H]3[C@@H](CCC4=C[C@H](O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO","inchiKey":"LPYXTAPPNYMYOP-XDBTXSBWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CORTISONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cortisone","NSC-9703"],"crossReferences":{"Wikipedia":["Cortisone"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1200534","canonicalSmiles":"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2cc(OC)c(OC)cc2C[C@H]1C(=O)O.Cl","inchiKey":"JXRAXHBVZQZSIC-JKVLGAQCSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MOEXIPRIL HYDROCHLORIDE","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1165","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Moexipril hydrochloride","Perdix","Univasc"],"synonyms":["CI 925","CI-925","Moexipril hcl","Moexipril hydrochloride","RS-10085-197","SPM 925","SPM-925"],"crossReferences":{"DailyMed":["moexipril%20hydrochloride"],"PubChem":["144206143","170465131"]},"linkedTargets":{"rows":["ENSG00000159640"],"count":1},"linkedDiseases":{"rows":["EFO_0000537"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1995 and is indicated for hypertension. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200668","canonicalSmiles":"[Ca+2].[Cl-].[Cl-]","inchiKey":"UXVMQQNJUSDDNG-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CALCIUM CHLORIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cal Plus","Calcium Chloride Dihydrate"],"synonyms":["Bovikalc","Cacl2","Cacl2 (anhydrous)","Calcarea muriatica","Calcium chloride","Calcium chloride anhydrous","Calcium chloride dihydrate","Calcium chloride hydrate","Calcium chloride solution","Calcium chloride, anhydrous","Dowflake","E-509","E509","INS NO.509","INS-509","Intergravin-orales","Kalgan","Liquidow","NSC-759598","Peladow"],"crossReferences":{"DailyMed":["calcium%20chloride"],"DrugCentral":["4201"],"PubChem":["144209783"],"Wikipedia":["Calcium_chloride"],"drugbank":["DB01164"],"chEBI":["3312"]},"childChemblIds":["CHEMBL2107795","CHEMBL2106539"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for hypocalcemia and has 5 investigational indications."}
{"id":"CHEMBL1201155","canonicalSmiles":"CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1.O=C(O)CCC(=O)O","inchiKey":"YQZBAXDVDZTKEQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LOXAPINE SUCCINATE","yearOfFirstApproval":1975,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL831","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Loxapac","Loxapine","Loxapine succinate","Loxitane"],"synonyms":["CL 71563","CL-71563","Loxapine succinate","NSC-759578"],"crossReferences":{"PubChem":["11112040","11112041","124881879","144203862","170465094","26719661","26747560","26747561","49731997","50106540","85231309","855705"],"chEBI":["6549"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1975. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201191","canonicalSmiles":"O=C(O)COCCN1CCN([C@H](c2ccccc2)c2ccc(Cl)cc2)CC1","inchiKey":"ZKLPARSLTMPFCP-OAQYLSRUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVOCETIRIZINE","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Xyzal"],"synonyms":["(-)-cetirizine","(r)-cetirizine","Cetirizine (r)-form","Cetirizine, (-)-","Cetirizine, (r)-","Levocetirizine","Xazal"],"crossReferences":{"DailyMed":["levocetirizine%20dihydrochloride"],"PubChem":["26719822","49681558"],"Wikipedia":["Levocetirizine"],"drugbank":["DB06282"]},"childChemblIds":["CHEMBL1201190"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","EFO_0008521","HP_0000989","HP_0012735","HP_0000964","EFO_0007533","MONDO_0005271","EFO_0000274","MONDO_0004784","EFO_0005531","Orphanet_79292","MONDO_0002406","EFO_0004142","MONDO_0004979","EFO_0007141","EFO_1001417","EFO_0003956","EFO_0007415"],"count":18},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2007 and has 6 approved and 13 investigational indications."}
{"id":"CHEMBL1201210","canonicalSmiles":"CCC(=O)c1ccc2c(c1)N(CC(C)N(C)C)c1ccccc1S2","inchiKey":"UVOIBTBFPOZKGP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROPIOMAZINE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["CB 1678","CB-1678","Dorevan","Dorevane","Indorm","Largon","Propavan","Propiomazine","WY-1359"],"crossReferences":{"Wikipedia":["Propiomazine"],"drugbank":["DB00777"],"chEBI":["8491"]},"childChemblIds":["CHEMBL1201068"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1960."}
{"id":"CHEMBL1201356","canonicalSmiles":"CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1","inchiKey":"UNBRKDKAWYKMIV-QWQRMKEZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLERGONOVINE","yearOfFirstApproval":1946,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Ergotyl","Methylergometrine","Methylergonovine"],"crossReferences":{"DailyMed":["methylergonovine%20maleate"],"PubChem":["104171343","144204360","170465383","26751766","50104453","90341291"],"Wikipedia":["Methylergometrine"],"drugbank":["DB00353"]},"childChemblIds":["CHEMBL1200843"],"linkedTargets":{"rows":["ENSG00000135914","ENSG00000184845"],"count":2},"linkedDiseases":{"rows":["MP_0001914"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1946 and is indicated for hemorrhage."}
{"id":"CHEMBL1201463","drugType":"Small molecule","blackBoxWarning":false,"name":"CODEINE POLISTIREX","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL485","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Codeine polistirex"],"crossReferences":{"DailyMed":["codeine%20polistirex"]},"linkedTargets":{"rows":["ENSG00000082556","ENSG00000116329","ENSG00000112038"],"count":3},"linkedDiseases":{"rows":["HP_0012735"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1985 and is indicated for cough."}
{"id":"CHEMBL1201497","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN GLARGINE","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Abasaglar","Abasaglar kwikpen","Basaglar","Ins lantus","Ins lantus opticlik","Ins lantus optiset","Ins lantus solostar","Lantus","Lantus solostar","Toujeo","Toujeo max solostar","Toujeo solostar"],"synonyms":["Basalin","Basalog","Galactus","Glargin","Glargine","Glaricon","HOE 71GT","HOE 901","HOE-71GT","HOE-901","Insulin Glargine Recombinant","Insulin glargine","Insulin glargine recombinant","Insulin glargine-yfgn","LY-2963016","LY2963016","Lantus r","Lusduna","MK-1293","MYL-1501D","Myl-1501d","Semglee"],"crossReferences":{"DailyMed":["insulin%20glargine","insulin%20glargine%20recombinant"],"DrugCentral":["4901"]},"linkedTargets":{"rows":["ENSG00000171105"],"count":1},"linkedDiseases":{"rows":["HP_0003124","EFO_0003095","EFO_0001645","HP_0011015","Orphanet_586","EFO_0003770","EFO_1000897","EFO_0000311","EFO_0000537","EFO_0000565","EFO_0003914","EFO_1001459","EFO_1001121","MONDO_0005147","HP_0003074","EFO_0000574","EFO_0000612","MONDO_0005148","EFO_0000400"],"count":19},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and has 3 approved and 11 investigational indications."}
{"id":"CHEMBL1201556","drugType":"Protein","blackBoxWarning":false,"name":"BECAPLERMIN","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Regranex"],"synonyms":["Becaplermin","GEM 21S","GEM-21S","Gemesis","Pdgf-2","Pdgf-bb","Pdgfb","Platelet-derived growth factor becaplermin","RWJ 60235","RWJ-60235","Sh-polypeptide-59"],"crossReferences":{"DailyMed":["becaplermin"],"DrugCentral":["4925"],"Wikipedia":["Becaplermin"]},"linkedTargets":{"rows":["ENSG00000134853","ENSG00000113721"],"count":2},"linkedDiseases":{"rows":["EFO_1001459","HP_0200042","MONDO_0043839","EFO_0005756"],"count":4},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and is indicated for skin ulcer and has 2 investigational indications."}
{"id":"CHEMBL1201632","drugType":"Enzyme","blackBoxWarning":false,"name":"IMIGLUCERASE","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cerezyme"],"synonyms":["Abcertin","Imiglucerase","Isu abxis","Isu-302"],"crossReferences":{"DailyMed":["imiglucerase"],"DrugCentral":["4932"],"Wikipedia":["Imiglucerase"]},"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1994 and has 5 approved indications."}
{"id":"CHEMBL1201639","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN ZINC SUSP BEEF","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lente insulin"],"synonyms":["Insulin zinc susp beef"],"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1229855","canonicalSmiles":"CC(=O)N(C)[C@H]1CC[C@H]([C@H](C)[C@H](N)C(=O)N2CC[C@H](F)C2)CC1","inchiKey":"BZFQBRSDORUYAB-YDMUCJKGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1229855","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06939"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230866","canonicalSmiles":"[Ag+]","inchiKey":"FOIXSVOLVBLSDH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SILVER","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Argentum metallicum","Ci 77820","Colloidal silver","E-174","E174","INS NO.174","INS-174","Nanosilver","Silver","Silver (e 174)","Silver colloidal","Silver nanoparticles","Silver, colloidal"],"crossReferences":{"drugbank":["DB14521"],"chEBI":["49468"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1236524","canonicalSmiles":"Nc1ncnc2c([C@@H]3N[C@H](CO)[C@@H](O)[C@H]3O)c[nH]c12","inchiKey":"AMFDITJFBUXZQN-KUBHLMPHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GALIDESIVIR","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BCX-4430","BCX4430","Bcx4430","Galidesivir","Immucillin a"],"crossReferences":{"drugbank":["DB11676"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1237080","canonicalSmiles":"CN1C2CCCC1CC(NC(=O)c1nn(C)c3ccccc13)C2.Cl","inchiKey":"QYZRTBKYBJRGJB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GRANISETRON HYDROCHLORIDE","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL289469","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Granisetron hydrochloride","Granisetron hydrochloride preservative free","Granisol","Granisteron HCl","Kytril"],"synonyms":["BRL 43694A","BRL-43694A","Bema granisetron","Granisetron (as hydrochloride)","Granisetron hcl","Granisetron hydrochloride","NSC-759839"],"crossReferences":{"DailyMed":["granisetron%20hydrochloride"],"PubChem":["124894588"]},"linkedTargets":{"rows":["ENSG00000166736"],"count":1},"linkedDiseases":{"rows":["HP_0100806","EFO_0000616","EFO_0006911","HP_0002017","HP_0002018"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and has 3 approved and 2 investigational indications."}
{"id":"CHEMBL1237212","canonicalSmiles":"O=C1OC(=O)[C@@H]2[C@H]1[C@H]1CC[C@H]2O1","inchiKey":"JAABVEXCGCXWRR-KAZBKCHUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NORCANTHARIDIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Demethylcantharidin","Isocantharidin","NSC-14003","NSC-59023","Norcantharidin"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1261","canonicalSmiles":"O=C(O)CC(O)(CC(=O)O)C(=O)O","inchiKey":"KRKNYBCHXYNGOX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CITRIC ACID","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Urologic G"],"synonyms":["Acidum citricum","Acidum citricum monohydrate","Aciletten","Anhydrous citric acid","B1650","Citrate","Citric Acid","Citric acid","Citric acid anhydrous","Citric acid bp","Citric acid hydrate","Citric acid monoglyceride","Citric acid, anhydrous","Citric acid, hydrous","Citric acid,anhydrous","Citric acid,hydrous","Citricum acidum","E-330","E330","FEMA NO. 2306","INS NO.330","INS-330","NSC-112226","NSC-30279","NSC-626579"],"crossReferences":{"DailyMed":["citric%20acid"],"PubChem":["144206986","144209603","17389961","26752850","47193731"],"Wikipedia":["Citric_acid"],"drugbank":["DB04272"],"chEBI":["30769"]},"childChemblIds":["CHEMBL2107737"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and has 6 investigational indications."}
{"id":"CHEMBL1351474","canonicalSmiles":"CC1=CC(=O)[N-]S(=O)(=O)O1.[K+]","inchiKey":"WBZFUFAFFUEMEI-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"ACESULFAME POTASSIUM","maximumClinicalTrialPhase":3,"parentId":"CHEMBL176687","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acesulfame k","Acesulfame potassium","Acesulfame potassium salt","E 950","E-950","E950","INS NO.950","INS-950","NSC-760104","Otizon","Potassium acesulfamate","Potassium acesulfame","Sunett d"],"crossReferences":{"PubChem":["144204552","144209621","17389209","26752766"],"Wikipedia":["Acesulfame_potassium"]},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1355821","canonicalSmiles":"COP(=S)(OC)Oc1ccc(Sc2ccc(OP(=S)(OC)OC)cc2)cc1","inchiKey":"WWJZWCUNLNYYAU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEMEFOS","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["27165","AC-52160","Abate","Abathion","Azai-ss","Biothion","Biothon","Difenphos","Difos","Diphos","EI-52160","ENT-27165","Ecopro 1707","Lavifos","NSC-755842","Nephis","Procida","Temefos","Temephos"],"crossReferences":{"PubChem":["144205628","144212095","170466375","26757325","50111598","93576704"],"drugbank":["DB12231"],"chEBI":["38954"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1454946","canonicalSmiles":"COC(=O)Nc1nc2cc(C(=O)c3ccc(F)cc3)ccc2[nH]1","inchiKey":"CPEUVMUXAHMANV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUBENDAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Flubendazole","NSC-313680","R 17,889","R-17,889","R-17889"],"crossReferences":{"PubChem":["174007180","26719867","49681603"],"drugbank":["DB08974"],"chEBI":["77095"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1495","canonicalSmiles":"CN1CCCN=C1COC(=O)C(O)(c1ccccc1)C1CCCCC1","inchiKey":"DUDKAZCAISNGQN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXYPHENCYCLIMINE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Oxyphencyclimine"],"crossReferences":{"drugbank":["DB00383"],"chEBI":["7868"]},"childChemblIds":["CHEMBL1200891"],"linkedTargets":{"rows":["ENSG00000133019","ENSG00000168539"],"count":2},"linkedDiseases":{"rows":["EFO_0010282"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for gastrointestinal disease."}
{"id":"CHEMBL152067","canonicalSmiles":"CC(C)(C)NCC(O)COc1ccc(NC(=O)NC2CCCCC2)cc1","inchiKey":"MXFWWQICDIZSOA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TALINOLOL","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Talinolol"],"crossReferences":{"PubChem":["144205724","170466514","26757961"],"Wikipedia":["Talinolol"],"drugbank":["DB11770"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1520837","canonicalSmiles":"CCCCCCCCN[C@@H](C)[C@H](O)c1ccc(SC(C)C)cc1","inchiKey":"BFCDFTHTSVTWOG-PXNSSMCTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GNF-Pf-1859","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GNF-Pf-1859"],"crossReferences":{"PubChem":["11112787","56422458","855693"],"drugbank":["DB13340"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1543","canonicalSmiles":"N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(=O)O)C(=O)O","inchiKey":"RWSXRVCMGQZWBV-WDSKDSINSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLUTATHIONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aec glutathione","Glutathione","Glutham","Isethion","L-glutathione reduced","Reduced l-glutathione","Tathione"],"crossReferences":{"PubChem":["144204924","170465600"],"Wikipedia":["Glutathione"],"drugbank":["DB00143"],"chEBI":["16856"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL1614637","canonicalSmiles":"CC(Oc1ccccc1)C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@H]12","inchiKey":"NONJJLVGHLVQQM-JHXYUMNGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENETHICILLIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[".alpha.-phenoxyethylpenicillin","Alfacilin","Feneticillin","NSC-117548","Pheneticillin","Synthepen"],"crossReferences":{"Wikipedia":["Pheneticillin"],"drugbank":["DB13337"],"chEBI":["52427"]},"childChemblIds":["CHEMBL2364720"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for bacterial disease."}
{"id":"CHEMBL1697847","drugType":"Small molecule","blackBoxWarning":false,"name":"POLYSORBATE 80","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Sorlate","Tween 80"],"synonyms":["E-433","E494","FEMA NO. 2917","INS NO.433","INS-433","Peg-20 sorbitan oleate","Polysorbata 80","Polysorbate 80","Sorbax pmo-20","Sorbimacrogol oleate 300","Tween-80"],"crossReferences":{"DrugCentral":["2227"],"PubChem":["144213782"],"Wikipedia":["Polysorbate_80"]},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL1701","canonicalSmiles":"CCOC(=O)C1(c2ccccc2)CCN(C)CC1.Cl","inchiKey":"WCNLCIJMFAJCPX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MEPERIDINE HYDROCHLORIDE","yearOfFirstApproval":1942,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL607","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Demerol","Meperidine hydrochloride","Meperidine hydrochloride preservative free","Pamergan","Pethidine","Pethilorfan","Spasmodlin"],"synonyms":["Meperidine hcl","Meperidine hydrochloride","Meperidine hydrochloride cii","NIH 10522","NSC-400479","Pethidine hydrochloride","Pethidini hydrochloridum"],"crossReferences":{"DailyMed":["meperidine%20hydrochloride"]},"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0003890","EFO_0003843","EFO_0005251"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1942 and is indicated for pain and drug dependence and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL180971","canonicalSmiles":"C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O","inchiKey":"IWHCAJPPWOMXNW-LYKMMFCUSA-N","drugType":"Protein","blackBoxWarning":false,"name":"PEPTIDE T","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Peptide t","Peptide-t"],"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL187718","canonicalSmiles":"CCCc1c(OC2CCCCC2)c2cc(Cl)ccc2[nH]c1=O","inchiKey":"BNZHKKGOSYAQSW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL187718","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07867"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL198408","canonicalSmiles":"COc1ccc(O)cc1NC(=O)NC(=O)c1ccc(F)cc1Cl","inchiKey":"RFOBTYLRURSVJE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL198408","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07968"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL20210","canonicalSmiles":"CCOC(=O)/C=C/[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@@H](CC(=O)[C@@H](NC(=O)c1cc(C)on1)C(C)C)Cc1ccc(F)cc1","inchiKey":"CAYJBRBGZBCZKO-BHGBQCOSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RUPINTRIVIR","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AG-7088","AG7088","Rupintrivir"],"crossReferences":{"drugbank":["DB05102"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2031465","canonicalSmiles":"Cc1ccc(C(=O)NC2CC2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O","inchiKey":"ZMAZXHICVRYLQN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-6703","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZ-12012199","AZ12012199","AZD-6703","Azd 6703","Azd-6703","Azd6703"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL203407","canonicalSmiles":"NS(=O)(=O)c1ccc(Nc2cc(OC3CCCCC3)nc3ncnn23)cc1","inchiKey":"RPJIMTALCNCQLV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL203407","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07688"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2103768","canonicalSmiles":"CN(C(=O)C(Cl)Cl)c1ccc(O)cc1","inchiKey":"GZZZSOOGQLOEOB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DILOXANIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diloxanide"],"crossReferences":{"drugbank":["DB08792"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2103811","canonicalSmiles":"Nc1nc(=O)c2c([nH]1)NCC1CN(c3ccc(C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])cc3)CN21.[Ca+2]","inchiKey":"AKUPTUNGFOADRT-ZEDZUCNESA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"FOLITIXORIN CALCIUM","maximumClinicalTrialPhase":3,"parentId":"CHEMBL117348","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ANX-510","COFACTOR","Folitixorin calcium"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2103829","canonicalSmiles":"CN(C)C[C@@H]1CCCC[C@H]1c1cccc(O)c1","inchiKey":"JIRYWFYYBBRJAN-ZFWWWQNUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FAXELADOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EM-906","EM906","Faxeladol","GCR-9905","GCR9905","GRT-TA300","GRTA-0009906","GRTA-9906","GRTA0009906","GRTA9906","Grt9906"],"childChemblIds":["CHEMBL3893776"],"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546","ENSG00000112038"],"count":3},"linkedDiseases":{"rows":["EFO_0005762","EFO_0005687","HP_0012532"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2104306","canonicalSmiles":"OCCN(CCO)c1nc(-c2ccccc2)c(-c2ccccc2)o1","inchiKey":"UUCMDZWCRNZCOY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DITAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ditazole","S-222"],"crossReferences":{"drugbank":["DB08994"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105567","canonicalSmiles":"NC(=O)c1cc[n+](CC2=C(C(=O)[O-])N3C(=O)[C@@H](NC(=O)Cc4cccs4)[C@H]3SC2)cc1","inchiKey":"FMZXNVLFJHCSAF-DNVCBOLYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFALONIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["41071","Cefalonium","Cephalonium","NSC-759292"],"crossReferences":{"PubChem":["144204099","170466431"],"drugbank":["DB11385"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105935","canonicalSmiles":"C[N+](C)(C)CCO.O=C([O-])C(O)C(O)C(=O)O","inchiKey":"QWJSAWXRUVVRLH-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHOLINE BITARTRATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Choline bitartrate"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2107802","canonicalSmiles":"Cc1cc(S(C)(=O)=O)c(S(C)(=O)=O)cc1C(=O)NC(=N)N","inchiKey":"GROMEQPXDKRRIE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIMEPORIDE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rimeporide"],"crossReferences":{"drugbank":["DB12861"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2108056","drugType":"Protein","blackBoxWarning":false,"name":"TORAPSEL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rpsgl-ig","Torapsel","WAY 164339","WAY-164339","YSPSL","Yspsl"],"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108078","drugType":"Protein","blackBoxWarning":true,"name":"PARATHYROID HORMONE","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Paroidin","Preotact"],"synonyms":["ALX-1-11","ALX-111","ALX1-11","NPSP-558","NPSP558","Natpar","Natpara","Parathormone (human recombinant)","Parathormonum","Parathyroid","Parathyroid hormone","Parathyroid hormone (rdna)","Pth (1-84)","Pth (1-84) human","Pth(1-84)"],"crossReferences":{"DrugCentral":["4936"]},"linkedTargets":{"rows":["ENSG00000160801"],"count":1},"linkedDiseases":{"rows":["HP_0002901","EFO_0003931","EFO_0003854","EFO_0000676","EFO_0009451","HP_0003418","EFO_0003882"],"count":7},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and is indicated for hypocalcemia and hypoparathyroidism and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2108335","drugType":"Gene","blackBoxWarning":false,"name":"SITIMAGENE CERADENOVEC","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sitimagene ceradenovec"],"description":"Gene drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2108509","drugType":"Protein","blackBoxWarning":false,"name":"INTERFERON ALFA-N1","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Wellferon"],"synonyms":["Interferon alfa-n1"],"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108510","drugType":"Protein","blackBoxWarning":false,"name":"INTERFERON BETA","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Avonex","Extavia","Interf b 1a","Interf b 1b","Interfb1a","Rebif"],"synonyms":["Fibroblast interferon","Human interferon beta","Interferon beta","Interferon beta natural","Interferon-beta"],"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2109057","drugType":"Antibody","blackBoxWarning":false,"name":"ECROMEXIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ecromeximab","KM-871","KM871","KW-281","KW-2871","KW2871"],"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2109199","drugType":"Small molecule","blackBoxWarning":false,"name":"MUCOPOLYSACCHARIDE POLYSULFATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mucopolysaccharide polysulfate"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2109295","drugType":"Antibody","blackBoxWarning":false,"name":"ASCRINVACUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ascrinvacumab","PF-03446962"],"linkedTargets":{"rows":["ENSG00000139567"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000770","EFO_0000182","EFO_1001951"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2109360","drugType":"Antibody","blackBoxWarning":false,"name":"AS-1403","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Therafab"],"synonyms":["AS-1403"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109552","drugType":"Antibody","blackBoxWarning":false,"name":"YTTRIUM Y 90 CAPROMAB PENDETIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Oncoltad"],"synonyms":["90Y-CYT-356","CYT-356-90Y","CYT-356-Y-90","Cyt-356 90y","Yttrium y 90 capromab pendetide"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2111101","canonicalSmiles":"CC(C)COc1ccc(CNC(=O)N(Cc2ccc(F)cc2)C2CCN(C)CC2)cc1","inchiKey":"RKEWSXXUOLRFBX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PIMAVANSERIN","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Pimavanserin"],"crossReferences":{"DailyMed":["pimavanserin%20tartrate"],"drugbank":["DB05316"]},"childChemblIds":["CHEMBL2448613"],"linkedTargets":{"rows":["ENSG00000102468"],"count":1},"linkedDiseases":{"rows":["MONDO_0005090","MONDO_0002009","MONDO_0005180","EFO_0004895","EFO_0005772","MONDO_0004975","EFO_0005407","HP_0000738"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2016 and has 3 approved and 7 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2178720","canonicalSmiles":"O=c1nc(NO)ccn1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O","inchiKey":"XCUAIINAJCDIPM-XVFCMESISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"N-HYDROXYCYTIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["N-hydroxycytidine"],"crossReferences":{"drugbank":["DB15660"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2220384","canonicalSmiles":"CCOC(=O)C1(c2ccccc2)CCC=CC1N(C)C","inchiKey":"WDEFBBTXULIOBB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TILIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dl-trans-tilidine","IDS-NT-003","Tilidine","Trans-tilidine"],"crossReferences":{"chEBI":["77817"]},"childChemblIds":["CHEMBL2218854"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL223512","canonicalSmiles":"O=C1Nc2cncc(n2)OCCCCCOc2ccc(Cl)cc2N1","inchiKey":"JRSWWYITYIOHOP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL223512","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07311"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL227452","canonicalSmiles":"CO/N=C(\\C(=O)NCB(O)O)c1csc(N)n1","inchiKey":"FMYGJTQJYFMFCR-XGICHPGQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFOTAXIME BATSI","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["cefotaxime BATSI"],"crossReferences":{"drugbank":["DB07599"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2355839","canonicalSmiles":"CNC(C)CCC=C(C)C.CNC(C)CCC=C(C)C.O=C(O)[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C(=O)O","inchiKey":"WSXKZIDINJKWPM-IBGZLQDMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOMETHEPTENE MUCATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1697841","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Midrid"],"synonyms":["Isometheptene mucate","Octin mucate"],"crossReferences":{"PubChem":["144206906"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for migraine disorder."}
{"id":"CHEMBL2364638","canonicalSmiles":"C[C@@H]1[C@H](c2ccccc2)C[C@H](NC(=O)c2cnc3c(c2)C[C@@]2(C3)C(=O)Nc3ncccc32)C(=O)N1CC(F)(F)F","inchiKey":"DDOOFTLHJSMHLN-ZQHRPCGSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"UBROGEPANT","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ubrelvy"],"synonyms":["MK-1602","Ubrogepant","Ubrogepant anhydrous"],"crossReferences":{"DailyMed":["ubrogepant"],"drugbank":["DB15328"]},"linkedTargets":{"rows":["ENSG00000064989"],"count":1},"linkedDiseases":{"rows":["MONDO_0005277"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2019 and is indicated for migraine disorder."}
{"id":"CHEMBL242237","canonicalSmiles":"NC(=O)c1ccccc1Nc1ccnc(Nc2cccc(O)c2)n1","inchiKey":"QHPKKGUGRGRSGA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL242237","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07268"],"chEBI":["40332"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL247272","canonicalSmiles":"c1ccc(-c2oc3ncnc(NCCN4CCNCC4)c3c2-c2ccccc2)cc1","inchiKey":"PTILEOLOGGMFCS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL247272","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07297"],"chEBI":["40432"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL251680","canonicalSmiles":"CCOP(=S)(OCC)Oc1ccc2c(C)c(Cl)c(=O)oc2c1","inchiKey":"BXNANOICGRISHX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"COUMAPHOS","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Baymix","Meldane"],"synonyms":["BAYER 21199","BAYER-21199","Coumafos","Coumaphos","NSC-8944"],"crossReferences":{"PubChem":["144204842","144209039","144211086","170466302","26747703","50107237","89854493"],"Wikipedia":["Coumaphos"],"drugbank":["DB11390"],"chEBI":["3903"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL259352","canonicalSmiles":"CCCCCCCC(=O)N[C@H]1CCOC1=O","inchiKey":"JKEJEOJPJVRHMQ-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL259352","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07928"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL259621","canonicalSmiles":"O=C(O)C[C@@H](Cc1ccccc1)C(=O)O","inchiKey":"GTOFKXZQQDSVFH-SECBINFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(R)-2-Benzylsuccinic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(R)-2-Benzylsuccinic Acid"],"crossReferences":{"drugbank":["DB07506"],"chEBI":["41241"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL263198","canonicalSmiles":"Nc1c2c(nc3c1CCCC3)CCCC2","inchiKey":"BMRFESVZYWRROS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OCTAAMINOACRIDINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL4297411"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL272427","canonicalSmiles":"C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C","inchiKey":"BHTRKEVKTKCXOH-LBSADWJPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAURURSODIOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tauroursodeoxycholic acid","Tauroursodesoxycholic acid","Taurursodiol","Ur-906","Ursodeoxy Cholic Acid","Ursodeoxycholyltaurine","Ursodoxicoltaurine"],"crossReferences":{"Wikipedia":["Tauroursodeoxycholic_acid"],"drugbank":["DB08834"],"chEBI":["80774"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL273862","canonicalSmiles":"CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3cc(O)ccc3nc2-1","inchiKey":"HAWSQZCWOQZXHI-FQEVSTJZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROXYCAMPTOTHECIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(s)-10-hydroxycamptothecin","10-Hydroxy Camptothecin","10-Hydroxy-Camptothecin","10-Hydroxycamptothecine","10-hcpt","10-hydroxycamptothecin","Hydroxycamptothecin","Irinotecan related compound a","NSC-107124"],"crossReferences":{"PubChem":["26750003","407052","50107786"],"drugbank":["DB12385"],"chEBI":["81395"]},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL28472","canonicalSmiles":"N[C@@H](CC1=CCCCc2onc(O)c21)C(=O)O","inchiKey":"HJEPOXZLPHUVFE-ZETCQYMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL28472","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04152"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL285063","canonicalSmiles":"C=CC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1","inchiKey":"HTUBKQUPEREOGA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PD-168393","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PD-168393"],"crossReferences":{"drugbank":["DB07662"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL289004","canonicalSmiles":"CC(=O)NCC(=O)O","inchiKey":"OKJIRPAQVSHGFK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACETURIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Acetamidoacetate","Aceturic Acid","Acetylamino-Acetic Acid","N-Acetylglycine"],"crossReferences":{"drugbank":["DB02713"],"chEBI":["40410"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3137321","canonicalSmiles":"COc1ccc2c3c1O[C@H]1C(OC(=O)c4ccccc4)=CC[C@@H]4[C@@H](C2)N(C)CC[C@@]341","inchiKey":"VPMRSLWWUXNYRY-NDOYXKHWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZHYDROCODONE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Benzhydrocodone"],"crossReferences":{"DailyMed":["benzhydrocodone%20hydrochloride"],"drugbank":["DB15465"]},"childChemblIds":["CHEMBL3137310"],"linkedTargets":{"rows":["ENSG00000082556","ENSG00000116329","ENSG00000112038"],"count":3},"linkedDiseases":{"rows":["EFO_0003890","EFO_0003843"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for pain and drug dependence."}
{"id":"CHEMBL315021","canonicalSmiles":"CCCCc1nc(CCCC)n(Cc2ccc(-c3ccccc3-c3nn[nH]n3)nc2)n1","inchiKey":"YONOBYIBNBCDSJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FORASARTAN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Forasartan","SC-52458"],"crossReferences":{"Wikipedia":["Forasartan"],"drugbank":["DB01342"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3186538","canonicalSmiles":"COC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)C3=CCC=CC3)[C@H]2SC1","inchiKey":"RDMOROXKXONCAL-UEKVPHQBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFROXADINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CGP 9000","CGP-9000","Cefroxadine","Cefthan-ds","Oraspor"],"crossReferences":{"PubChem":["144206693"],"drugbank":["DB11367"],"chEBI":["31379"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3264610","canonicalSmiles":"CC(C)[C@](O)(c1ccc2cc(OC(F)F)c(OC(F)F)cc2c1)c1c[nH]nn1","inchiKey":"ZBRAJOQFSNYJMF-SFHVURJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SEVITERONEL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Seviteronel","Vt-464"],"crossReferences":{"drugbank":["DB12275"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3392104","canonicalSmiles":"Cl.Cl[Te]1(Cl)OCCO1.N","inchiKey":"VSJCJBQENUBFJC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMMONIUM TRICHLORO(DIOXOETHYLENE-O,O'-)TELLURATE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL3546168","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ammonium trichloro(dioxoethylene-o,o'-)tellurate"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545144","drugType":"Small molecule","blackBoxWarning":false,"name":"TAS-115","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pamufetinib","Tas-115"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545211","canonicalSmiles":"CCN(CC)Cc1ccc(OCC[C@H]2CCC3C4C(CC[C@@]32C)c2ccc(O)cc2C[C@H]4C)c(OC)c1","inchiKey":"OHCPNHFLPCVWRG-YQOGLFJVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SR16234","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL3545210"],"linkedTargets":{"rows":["ENSG00000091831"],"count":1},"linkedDiseases":{"rows":["MONDO_0007254"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3634131","canonicalSmiles":"CN(C)Cc1ccc2c(Cl)cc(Cl)c(O)c2n1","inchiKey":"YZPOQCQXOSEMAZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3634131","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB05565"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707288","canonicalSmiles":"O=C([O-])CCC(=O)[O-].[Li+].[Li+]","inchiKey":"WAHQBNXSPALNEA-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"LITHIUM SUCCINATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lithium succinate"],"crossReferences":{"DrugCentral":["4590"],"drugbank":["DB14508"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL384467","canonicalSmiles":"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO","inchiKey":"UREBDLICKHMUKA-CXSFZGCWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXAMETHASONE","yearOfFirstApproval":1958,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aeroseb-dex","Dalalone","Decaderm","Decadron","Decadron-75","Decaspray","Dexacortisyl","Dexafree","Dexamethasone","Dexamethasone intensol","Dexone","Dexone 0.5","Dexone 0.75","Dexone 1.5","Dexone 4","Dexsol","Dextenza","Dexycu kit","Dropodex","Gppe ear spy","Hemady","Hexadrol","Kortico Injection","Martapan","Maxidex","Maxitrol","Oradexon","Otomize","Ozurdex","Sofradex","Spersadex comp","Tobradex"],"synonyms":["Decadron-LA","Dexacen-4","Dexacort","Dexair","Dexamethasone","Dexamethasone metasulfobenzoate sodium","Dexamethasone palmitate","Dexamethasone valerate","Dexycu","Fluormethylprednisolone","ISV-305","Mymethasone","NSC-34521","Neodecadron","OTO-104"],"crossReferences":{"DailyMed":["dexamethasone"],"PubChem":["144207320","17389945","26752876","26752877","26752878","56314873","56320685","92119"],"Wikipedia":["Dexamethasone"],"drugbank":["DB01234"],"chEBI":["41879"]},"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0010822","MONDO_0100130","EFO_0000681","EFO_0009536","EFO_0005952","EFO_0009322","EFO_1001129","EFO_0005773","EFO_1001909","EFO_1000797","EFO_1001951","MONDO_0001903","EFO_0003103","EFO_0000588","EFO_0009560","EFO_0000096","EFO_0002690","EFO_1001366","MONDO_0016047","EFO_0008528","EFO_0000676","EFO_0008517","EFO_0000400","HP_0003072","EFO_0000221","EFO_0009686","EFO_1000811","HP_0012532","EFO_0009449","HP_0009926","EFO_1001946","EFO_0000546","MONDO_0002691","MONDO_0044889","EFO_1000049","EFO_0009688","EFO_0003957","MONDO_0016226","MONDO_0002406","MONDO_0004979","EFO_0001378","EFO_0000341","EFO_0000516","MONDO_0015564","EFO_0009491","EFO_0003073","EFO_1001896","EFO_0001365","EFO_0004992","MONDO_0005271","EFO_1000684","Orphanet_790","EFO_1001012","EFO_0007297","MONDO_0003541","EFO_1000637","MONDO_0004565","MONDO_0000465","EFO_0003966","MONDO_0001056","EFO_0009430","MONDO_0002050","EFO_1000694","EFO_0000196","EFO_0007231","EFO_0000183","EFO_1001417","MONDO_0002083","EFO_0005752","HP_0002094","HP_0000486","EFO_0008590","EFO_0000403","HP_0011110","EFO_0003898","EFO_1001875","MONDO_0007576","EFO_0001358","HP_0003418","EFO_0000618","EFO_0003843","EFO_1002002","MONDO_0006412","HP_0002315","EFO_0007149","MONDO_0011962","EFO_0000702","EFO_1001947","MONDO_0024880","MONDO_0005178","EFO_0004710","MONDO_0000873","EFO_0004683","EFO_0007200","MONDO_0041052","EFO_0001075","EFO_0005592","EFO_0004274","EFO_1000657","EFO_0002426","EFO_0000565","EFO_0000309","EFO_0007160","EFO_0009456","EFO_0007520","EFO_1000786","EFO_0004253","MONDO_0015540","MONDO_0100053","EFO_0009552","EFO_0007541","MONDO_0004768","EFO_1002012","EFO_1000749","EFO_0004719","EFO_0009441","EFO_0003802","HP_0000360","EFO_0003893","MONDO_0004658","MONDO_0002122","EFO_1000039","MONDO_0021144","MONDO_0044881","HP_0001873","EFO_1001119","HP_0100806","MP_0001845","EFO_1000986","HP_0030833","EFO_0004888","EFO_0006862","MONDO_0019471","EFO_1001494","EFO_1001984","EFO_1000764","EFO_1001435","MONDO_0001280","MONDO_0044887","HP_0001094","EFO_1001469","HP_0001915","MONDO_0001187","HP_0004398","MONDO_0005277","MONDO_0001718","EFO_0009507","Orphanet_70589","MONDO_0005129","HP_0002017","MONDO_0001657","EFO_0004212","EFO_0004272","EFO_0003932","EFO_0007427","HP_0002015","EFO_0003917","EFO_0009321","EFO_0007490","EFO_0009609","EFO_0009869","MONDO_0015128","HP_0000265","EFO_0007344","EFO_0003894","EFO_0000613","EFO_0003060","EFO_0006912","EFO_0006738","EFO_0009450","EFO_0007227","EFO_0007228","MONDO_0005301","EFO_0000095","EFO_0006475","EFO_0007403","EFO_0001068","EFO_1001936","EFO_0005611","EFO_0003811","EFO_0003027","EFO_0004190","Orphanet_64739","EFO_0011061","EFO_0004708","EFO_0000365","EFO_0007486","EFO_0000275","EFO_0000756","MONDO_0002959","MONDO_0018896","HP_0011868","Orphanet_85443","HP_0011950","EFO_0003964","EFO_1000992","EFO_1000318","EFO_0003931","EFO_1001935","MONDO_0008903","EFO_0003884","EFO_0004616","MONDO_0002331","EFO_0000198","EFO_0002618","MONDO_0013730","EFO_0006911","EFO_1000906","EFO_0005323","EFO_0001642","EFO_1001968","HP_0001742","EFO_0000384","MONDO_0008315","EFO_0005221","EFO_0009448","EFO_0001663","MONDO_0100431","MP_0001914","EFO_1000760","EFO_0001422","EFO_0003032","EFO_0000678","MONDO_0000831","MONDO_0019472","EFO_0000574","MONDO_0002258","EFO_0003086","EFO_0007405","EFO_1000997","EFO_1001205","MONDO_0021108","EFO_1000879","EFO_0002913","MONDO_0007254","EFO_0009657","EFO_0000284","EFO_0004252","EFO_0009760","EFO_0003959","EFO_0009514","EFO_0004289","Orphanet_1930","EFO_0004238","EFO_0009625","EFO_1002005","Orphanet_797","EFO_0000616","EFO_0000694","EFO_1000829","EFO_1001779","EFO_0006859","EFO_1001157","EFO_0000222","MONDO_0000870","EFO_1001267","EFO_0000537","EFO_1001961","EFO_1000140","EFO_0007257","HP_0030839","EFO_0000684","MONDO_0021148","EFO_1001194","EFO_0007141","MONDO_0018906","MONDO_0001572","EFO_0009515","EFO_0003956","EFO_0000729","EFO_0003869","EFO_1000845","EFO_0008571","EFO_0009373","EFO_1000131","EFO_0005558","HP_0002018","EFO_0008997","EFO_0000544","MONDO_0002471","MONDO_0019460","EFO_0000182","EFO_0000330","EFO_0004255","EFO_1001176","EFO_0007332","EFO_0004208","HP_0012378","EFO_0000094","EFO_0004276","EFO_1001250","EFO_0005854","EFO_0000220","MONDO_0008170","Orphanet_3389","EFO_0000223","EFO_0004236","EFO_0000224","EFO_0003025","Orphanet_418","EFO_0009708","MONDO_0100096","Orphanet_90794","MONDO_0044917","EFO_1001051","HP_0012424","EFO_0000218","Orphanet_314701","EFO_0000699","EFO_1001115","EFO_0005251","EFO_1001792","EFO_1001222","MONDO_0037255","MONDO_0009348","MONDO_0003005","EFO_0006951","EFO_0003812","EFO_0005319","EFO_1000965","Orphanet_232","EFO_1001945","EFO_0003778","EFO_0000373","EFO_0000274","MONDO_0002462","EFO_0000708","EFO_0000209","EFO_0000305","MONDO_0020657","EFO_0002950","EFO_1001480","EFO_1001216","EFO_1001801","HP_0030834","EFO_1001830","EFO_0000673","HP_0002013","MONDO_0020743","EFO_0003769","EFO_1000726","EFO_0010580","EFO_0000685","EFO_0000545","EFO_0005207","EFO_0003770","EFO_1000941","EFO_0005755","EFO_0002609","EFO_0000311","MONDO_0001705","EFO_0000211","EFO_0003106","EFO_0004237","EFO_0005570","EFO_0000713","EFO_0000706","EFO_0000691","EFO_0000181","EFO_0001063"],"count":360},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1958 and has 73 approved and 200 investigational indications."}
{"id":"CHEMBL3989857","canonicalSmiles":"O.O.O.O.O.O.O.O=S(=O)([O-])[O-].[Mg+2]","inchiKey":"WRUGWIBCXHJTDG-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"MAGNESIUM SULFATE","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2021423","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Epsom Salt","Mag sulf","Magnesium sulfate","Original andrews salts"],"synonyms":["Epsom salt","Epsom salt(heptahydrate)","Magnesia sulphurica","Magnesii sulfatis heptahydras","Magnesium sulfate","Magnesium sulfate heptahydrate","Magnesium sulphate"],"crossReferences":{"DailyMed":["magnesium%20sulfate"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and has 8 approved and 50 investigational indications."}
{"id":"CHEMBL3989980","drugType":"Antibody","blackBoxWarning":false,"name":"LARCAVIXIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Zmapp"],"synonyms":["Larcaviximab","c4G7"],"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3990012","drugType":"Protein","blackBoxWarning":false,"name":"PEGAPAMODUTIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-2944876","LY2944876","Pegapamodutide"],"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL410807","canonicalSmiles":"CC[C@H]1C[C@H](C)[C@@]2(NC1=O)O[C@@H](C[C@H](O)[C@@H](C)CC/C=C/C=C(\\C)[C@@H]1C/C=C/C=C/[C@H](O)[C@H](C)[C@@H](O)[C@@H](CCC(C)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc3cccc(O)c3)C(=O)N3CCC[C@H](N3)C(=O)O1)[C@H](C)[C@H](O)[C@@H]2C","inchiKey":"ONJZYZYZIKTIEG-CFBQITSMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SANGLIFEHRIN A","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03393"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL422872","canonicalSmiles":"O=C(O)CSC(CCCc1ccccc1)c1ccc(OCc2ccc3ccccc3n2)cc1","inchiKey":"JOIXGLLMSDPZDN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-4769","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZ-12096971","AZD-4769","Azd-4769"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297246","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"LADEMIRSEN SODIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lademirsen sodium","RG-012","RG-012 SODIUM","RG456070"],"description":"Oligonucleotide drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297348","canonicalSmiles":"CC(C)C[C@@H](NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H]1CCCN1C(=O)[C@@H](CCC(N)=O)NC(=O)[C@H](NC(=O)[C@H]1CCCN1C(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CO)NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@H](N)CC(=O)O)C(C)C)C(=O)N[C@H](CC(N)=O)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCCN)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCNC(=N)N)C(=O)N1CCC[C@@H]1C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCNC(=N)N)C(=O)NCC(=O)O)[C@H](C)O)[C@H](C)O","inchiKey":"HRMVIAFZYCCHGF-BMCUWHFPSA-N","drugType":"Protein","blackBoxWarning":false,"name":"BRIMAPITIDE, C-TERMINAL ACID","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AM-111","Am-111","Brimapitide, c-terminal acid","D-jnki-1","Xg-102 c-terminal acid"],"linkedTargets":{"rows":["ENSG00000109339"],"count":1},"linkedDiseases":{"rows":["EFO_0004238"],"count":1},"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297357","canonicalSmiles":"N[C@H](Cc1ccc(OC[18F])cc1)C(=O)O","inchiKey":"GEBHVOHKNWLITQ-DEVVULMSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"D-FLUOROMETHYLTYROSINE F-18","maximumClinicalTrialPhase":1,"parentId":"CHEMBL4302826","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(18f)d-fmt","(d)-18f-fluoromethyltyrosine","(f18)-d-fmt","BAY 86-9596","BAY-86-9596","BAY-86-9596 F-18","BAY-869596","BAY-869596-","BAY86-9596","Bay86-9596","D-(18f)fmt","D-fluoromethyltyrosine f-18","J2.566.882K"],"crossReferences":{"drugbank":["DB15296"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297383","canonicalSmiles":"Fc1cc(-c2cccc(-c3nc[nH]n3)c2)cc(F)c1CNC1Cc2ccccc2C1","inchiKey":"WIEDUMBCZQRGSY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK-1521498","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK1521498","Gsk-1521498","Gsk1521498"],"crossReferences":{"drugbank":["DB12886"]},"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["MONDO_0007079","EFO_0001073"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297443","drugType":"Small molecule","blackBoxWarning":false,"name":"TECHNETIUM TC-99M","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1201315","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Technegas","Technetium (99mtc)","Technetium (tc 99m)","Technetium 99m","Technetium 99m metal","Technetium tc 99m","Technetium tc-99m","Technetium, tc-99m","Technetium,tc-99m"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297507","canonicalSmiles":"C[C@H]1CN(C(=O)CC#N)[C@]12CCN(c1ncnc3[nH]ccc13)C2","inchiKey":"LOWWYYZBZNSPDT-ZBEGNZNMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DELGOCITINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Delgocitinib","JTE-052","JTE-052A","LEO 124249","LEO 124249A","LEO-124249","LEO-124249A"],"linkedTargets":{"rows":["ENSG00000096968","ENSG00000162434","ENSG00000105639","ENSG00000105397"],"count":4},"linkedDiseases":{"rows":["EFO_0004192","HP_0000964","EFO_0000676","MONDO_0019558","EFO_0000274"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4297718","drugType":"Unknown","blackBoxWarning":false,"name":"CD40 LIGAND","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG-950","Cd40 ligand","Cd40 ligand recombinant","Recombinant cd40-ligand","Recombinant human cd40 ligand","Soluble cd154 recombinant"],"linkedTargets":{"rows":["ENSG00000101017"],"count":1},"linkedDiseases":{"rows":["EFO_0000389"],"count":1},"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297796","drugType":"Unknown","blackBoxWarning":false,"name":"NERVE GROWTH FACTOR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[".beta.-ngf","Beta-nerve growth factor","Nerve growth factor","Nerve growth factor .beta.","Nerve growth hormone","Rh-polypeptide-14"],"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297806","drugType":"Unknown","blackBoxWarning":false,"name":"PF-06747143","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-06747143","Pf-06747143"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297888","drugType":"Antibody","blackBoxWarning":false,"name":"SOTIGALIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["APX-005","APX-005M","APX005M","Apx-005m","Apx005m","EPI-0050","Sotigalimab"],"linkedTargets":{"rows":["ENSG00000101017"],"count":1},"linkedDiseases":{"rows":["EFO_1000044","EFO_0000756","MONDO_0008170","EFO_1000657","MONDO_0007576","EFO_1001968","EFO_0002617"],"count":7},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4297942","drugType":"Antibody","blackBoxWarning":false,"name":"QUETMOLIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E-6011","E6011","Quetmolimab"],"linkedTargets":{"rows":["ENSG00000006210"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_1001486","EFO_0000384"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4298048","drugType":"Unknown","blackBoxWarning":false,"name":"MP-0250","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MP-0250","MP0250","Mp-0250","Mp0250"],"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4298065","drugType":"Unknown","blackBoxWarning":false,"name":"OMEGA-3 FATTY ACIDS","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NDI 441","Omega 3 fatty acids","Omega-3","Omega-3 acid","Omega-3 acid triglycerides","Omega-3 acids","Omega-3 fatty acids","Omega-3 phospholipids","Omega-3 polyunsaturates","Omega-3 triglycerides","Omega-3-acid triglycerides","Phospholipids"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL440115","canonicalSmiles":"O=C(/C=C/c1c(-c2ccccc2)nn2ccccc12)N1CCCC[C@@H]1CCO","inchiKey":"OPLOPFHUHFGKMJ-JXOMPUQVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FK453","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FK-453","Fk453"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL45305","canonicalSmiles":"Cc1ccc(CNCC2(F)CCN(C(=O)c3ccc(F)c(Cl)c3)CC2)nc1","inchiKey":"PKZXLMVXBZICTF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BEFIRADOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Befiradol","F-13640","F13640","NLX-112"],"crossReferences":{"Wikipedia":["Befiradol"]},"linkedTargets":{"rows":["ENSG00000178394"],"count":1},"linkedDiseases":{"rows":["EFO_0004280"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL4594444","canonicalSmiles":"C[C@H](O)c1nc(Cn2nc(-c3ccc(Cl)cc3)n(C[C@H](O)C(F)(F)F)c2=O)nn1-c1cccc(Cl)c1","inchiKey":"AZXOTZCWQDJCLY-SJCJKPOMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PECAVAPTAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY 1753011","BAY-1753011","Bay 1753011","Pecavaptan"],"linkedTargets":{"rows":["ENSG00000126895","ENSG00000166148"],"count":2},"linkedDiseases":{"rows":["EFO_0003144"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594459","drugType":"Unknown","blackBoxWarning":false,"name":"APG-1387","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["APG-1387","APG-1387 (SMAC MIMETIC)","Apg-1387","SM-1387"],"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4594514","drugType":"Antibody","blackBoxWarning":false,"name":"MIRZOTAMAB CLEZUTOCLAX","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABBV-155","Abbv-155","Mirzotamab clezutoclax"],"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594573","drugType":"Unknown","blackBoxWarning":false,"name":"LY-3016859","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-3016859","LY3016859","Ly-3016859","Ly3016859"],"linkedTargets":{"rows":["ENSG00000124882","ENSG00000163235"],"count":2},"linkedDiseases":{"rows":["EFO_0005762","EFO_0000401","HP_0003419","MONDO_0005178"],"count":4},"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4594599","drugType":"Enzyme","blackBoxWarning":false,"name":"GLUTAMATE DECARBOXYLASE 2","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diamyd antigen gad-65","Gad-65","Gad65","Glutamate decarboxylase 2","Rhgad65","Rhugad65"],"description":"Enzyme drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL460657","canonicalSmiles":"CCCCCCCC/C=C/CCCCCCCC(=O)O","inchiKey":"ZQPPMHVWECSIRJ-MDZDMXLPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELAIDIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Elaidic Acid","Octadec-9-Enoic Acid Anion"],"crossReferences":{"Wikipedia":["Elaidic_acid"],"drugbank":["DB04224"],"chEBI":["27997"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL462018","canonicalSmiles":"CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23","inchiKey":"URLYINUFLXOMHP-HTVVRFAVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRICIRIBINE PHOSPHATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-154020","NSC-280594","Phosphate salt of tricyclic nucleoside","Triciribine","Triciribine phosphate","Vqd-002"],"crossReferences":{"drugbank":["DB14636"]},"linkedTargets":{"rows":["ENSG00000105221","ENSG00000117020","ENSG00000142208"],"count":3},"linkedDiseases":{"rows":["EFO_0000565","EFO_0000304","MONDO_0008170","EFO_0000311"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4650518","drugType":"Antibody","blackBoxWarning":false,"name":"PLONMARLIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Plonmarlimab","TJ-003234","TJ003234","TJM-2","Tj003234"],"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4651083","canonicalSmiles":"COCCCOc1cccc(C[S+]([O-])c2nc3cc4c(cc3[nH]2)OCC4)c1C","inchiKey":"JYSIFLQJDVIWKM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANAPRAZOLE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL4650347"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL488025","canonicalSmiles":"CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\\c1ccc(S(C)(=O)=O)cc1","inchiKey":"MVGSNCBCUWPVDA-MFOYZWKCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EXISULIND","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aptosyn","Exisulind","Prevatec","Sulindac related compound b","Sulindac sulfone"],"crossReferences":{"PubChem":["11111778","144207073","170466321","50107023","85231220"],"drugbank":["DB06246"],"chEBI":["64212"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL49","canonicalSmiles":"O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1","inchiKey":"QWCRAEMEVRGPNT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUSPIRONE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["BCI-024","Buspar","Buspirone","Gen-buspirone"],"crossReferences":{"DailyMed":["buspirone%20hydrochloride"],"PubChem":["104171117","11110857","11112732","11113821","144203643","144212688","170464909","26751994","90340780"],"Wikipedia":["Buspirone"],"drugbank":["DB00490"],"chEBI":["3223"]},"childChemblIds":["CHEMBL1200399"],"linkedTargets":{"rows":["ENSG00000178394"],"count":1},"linkedDiseases":{"rows":["EFO_0003888","EFO_0003756","MONDO_0005090","EFO_0004240","EFO_0002610","HP_0002140","EFO_0006788","MONDO_0002009","HP_0000726","EFO_1001919","EFO_0003758","EFO_1000948","EFO_0008533","EFO_0007191","EFO_1001892","EFO_0004714","MONDO_0002050","HP_0002045","MONDO_0005180","EFO_0004888","EFO_0005230","HP_0002104","EFO_0005411","EFO_0000717"],"count":24},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and has 4 approved and 19 investigational indications."}
{"id":"CHEMBL510539","canonicalSmiles":"C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](OCCc3ccc(O)c(O)c3)O[C@H](CO[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H]2OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H](O)[C@H](O)[C@H]1O","inchiKey":"FSBUXLDOLNLABB-ISAKITKMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL510539","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144208143","17389021"],"drugbank":["DB15488"],"chEBI":["4745"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL55","canonicalSmiles":"N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1","inchiKey":"XDRYMKDFEDOLFX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PENTAMIDINE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nebupent [as isethionate]","Pentacarinat","Pentacarinat [as isethionate]","Pentam 300 [as isethionate]"],"synonyms":["GNF-Pf-3680","MB 800 FREE BASE","MB 800 [AS ISETHIONATE]","MB-800","MB-800 (AS ISETHIONATE)","MB-800 FREE BASE","Mp-601205","NSC-9921","Pentam 300","Pentamidine","Pentamidine isetionate","RP 2512 FREE BASE","RP 2512 [AS ISETHIONATE)","RP-2512","RP-2512 FREE BASE"],"crossReferences":{"DailyMed":["pentamidine%20isethionate"],"PubChem":["50123735","50123736","75273"],"Wikipedia":["Pentamidine"],"drugbank":["DB00738"],"chEBI":["45081"]},"childChemblIds":["CHEMBL935","CHEMBL543544","CHEMBL494163","CHEMBL361506"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and has 4 approved and 14 investigational indications."}
{"id":"CHEMBL560592","canonicalSmiles":"NCC(=O)N1C[C@H](NC(=O)c2ccccc2)C[C@H]1C(=O)O","inchiKey":"BIZKIHUJGMSVFD-MNOVXSKESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DANEGAPTIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Danegaptide","GAP-134","ZP-1609","ZP1609"],"crossReferences":{"drugbank":["DB11821"]},"childChemblIds":["CHEMBL453105"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL571159","canonicalSmiles":"COCCOc1cc2ncc3c(N)nc(-n4ccnc4)cc3c2cc1OC","inchiKey":"QSSGYSRUMIOURP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL571159","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07300"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL573077","canonicalSmiles":"COc1cc(-c2c(C)cccc2C)cc([C@@H](C)C#Cc2c(C)nc(N)nc2N)c1","inchiKey":"XZXVRKHUCSXVBM-AWEZNQCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL573077","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07144"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL77484","canonicalSmiles":"O=C(O)[C@H]1CCCNC1","inchiKey":"XJLSEXAGTJCILF-YFKPBYRVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(S)-NIPECOTIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(S)-Nipecotic Acid","Piperidine-3-Carboxylic Acid"],"crossReferences":{"PubChem":["11110662","11113421"],"drugbank":["DB08849"],"chEBI":["222169"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL809","canonicalSmiles":"CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21","inchiKey":"VGKDLMBJGBXTGI-SJCJKPOMSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"SERTRALINE","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Sertraline"],"crossReferences":{"DailyMed":["sertraline%20hydrochloride"],"PubChem":["26753299","29215139","49665783","50105682","50105683","50105684","50105685","90341218"],"Wikipedia":["Sertraline"],"drugbank":["DB01104"],"chEBI":["9123"]},"childChemblIds":["CHEMBL1709"],"linkedTargets":{"rows":["ENSG00000108576"],"count":1},"linkedDiseases":{"rows":["MONDO_0005090","HP_0000989","EFO_0004262","EFO_0002610","MONDO_0002009","EFO_0007453","HP_0000726","EFO_0003847","EFO_1002014","EFO_1001917","EFO_0007211","EFO_0004698","MONDO_0002046","EFO_0004247","EFO_0000289","MONDO_0002050","EFO_0003761","MONDO_0001162","EFO_0003047","EFO_0004242","MONDO_0007079","EFO_0005230","EFO_0000198","EFO_0003756","EFO_0003758","EFO_0000222","EFO_0001358","EFO_0001073","HP_0002315","EFO_0000537","Orphanet_908","EFO_0007228","Orphanet_399","EFO_0008623","EFO_1001892","EFO_0003890","EFO_0007634","MONDO_0043510","EFO_0000519"],"count":39},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and has 7 approved and 32 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL9324","canonicalSmiles":"CC[N+](CC)(CC)CC","inchiKey":"CBXCPBUEXACCNR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TETRYLAMMONIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-102778","NSC-156315","Tetraethylammonium cation","Tetraethylammonium ion","Tetramon"],"crossReferences":{"PubChem":["11111868","50111261","90340838"],"Wikipedia":["Tetraethylammonium"],"drugbank":["DB08837"],"chEBI":["44296"]},"childChemblIds":["CHEMBL434435","CHEMBL2425619","CHEMBL324254"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
